美股A股
StockGist

BrightSpring Health Services, Inc. Common Stock

BTSGNASDAQ · Healthcare · Medical - Healthcare Information Services
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States.
$71.21-0.34%
报价 2026-11-13
市值
$14.17B
EV
$15.02B
PE (TTM)
40.9x
预期 PE (FY2026)
37.1x
52 周区间距高点 -2.3%
$31.36$72.91

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

爆发潜力

2026-11-13
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22027-121.2x1.71 → 2.48(1.5x)28.7
FY+32028-121.4x1.71 → 3.10(1.8x)23.0

毛利率 13% · TTM 收入 $15251M · 基数 EPS 1.71(调整后)

电话会信号

辅助标签
Q3 20262026-10-30
扩产上调指引供不应求
指引 上调
信心 4
分析师 4

“We still anticipate and reiterate from Analyst Day at least 15% to 20% organic adjusted EBITDA growth in 2027.”

原文引用(3)
  • 扩产:we are continuing to build capacity in our business over time
  • 上调指引:Total adjusted EBITDA is now expected to be in the range of $850 million to $860 million for the full year 2026.
  • 供不应求:Demand for services continues to outstrip our ability to provide them

蓝色标签在暴涨研究中略有区分度;悬停查看口径。

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
BTSGBrightSpring Health Services, Inc. Common Stock$14.17B-0.3%+25.7%12.3%40.9x21.2x27.1x
BRKRBruker Corporation$9.41B+2.1%+3.4%49.1%–90.1x38.9x
KRYSKrystal Biotech, Inc.$9.05B-0.1%+28.4%92.6%35.3x40.7x29.2x
HQYHealthEquity, Inc.$8.56B+0.4%+8.0%69.5%32.7x23.7x18.1x
CHEChemed Corporation$7.13B-0.4%+7.2%31.1%19.7x12.6x24.1x
TFXTeleflex Incorporated$6.15B+1.3%-31.3%53.3%–63.6x15.9x
RDNTRadNet, Inc.$6.02B+0.5%+25.3%13.5%–25.6x–
MMSIMerit Medical Systems, Inc.$5.19B-0.1%+8.4%48.7%31.5x13.5x25.4x
STVNStevanato Group S.p.A.$4.32B+10.0%+8.1%29.1%24.6x12.3x–
同行中位数––+8.0%48.9%31.5x24.7x24.8x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-09-30
Q3 2026
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
Revenue$4.21B$3.87B$3.61B$3.55B$3.33B$3.15B$2.88B$3.05B
Gross Margin12.3%12.7%13.3%11.6%11.8%11.9%11.8%13.8%
Operating Margin3.8%3.7%3.8%3%2.6%1.5%1.8%2.6%
Net Income$100.1M$86.7M$74.4M$77.1M$55.8M$28.2M$29.5M$16M
Diluted EPS0.450.390.340.350.260.130.140.08
Operating Cash Flow$204.3M$43.9M$122.9M$231.6M$107.9M$49.1M$101.6M$90.6M

研究材料